Teleflex (TFX) Cash from Financing Activities (2009 - 2026)
Teleflex (TFX) posted Cash from Financing Activities of -$45.0 million for Q1 2026, up 26.98% on a QoQ basis from -$61.6 million in Q4 2025, and up 24.43% year-over-year from -$36.2 million in Q1 2025.
Teleflex (TFX) Cash from Financing Activities (2009 - 2026) Analysis & Trends
Teleflex's Cash from Financing Activities history runs 18 years deep, the most recent figure standing at -$45.0 million for Q1 2026.
- Quarterly Cash from Financing Activities rose 24.43% year-over-year to -$45.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $626.1 million (up 252.7% YoY) and the FY2025 annual result came in at $611.5 million, up 244.94% from the prior year.
- Cash from Financing Activities was -$45.0 million for Q1 2026 at Teleflex, up from -$61.6 million in the prior quarter.
- Across five years, Cash from Financing Activities topped out at $756.3 million in Q3 2025 and bottomed at -$237.5 million in Q4 2023.
- A 5-year average of -$2.0 million and a median of -$59.5 million in 2025 frame the typical range for Cash from Financing Activities.
- Peak annual rise in Cash from Financing Activities reached 1904.6% in 2023, while the deepest fall reached 1286.22% in 2023.
- Teleflex's Cash from Financing Activities stood at -$17.1 million in 2022, then plunged by 1286.22% to -$237.5 million in 2023, then jumped by 49.85% to -$119.1 million in 2024, then surged by 48.28% to -$61.6 million in 2025, then grew by 26.98% to -$45.0 million in 2026.
- Business Quant data shows TFX's Cash from Financing Activities at -$45.0 million in Q1 2026, -$61.6 million in Q4 2025, and $756.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | -133.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | -287.90 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -414.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | -13.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | -255.24 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | -164.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -75.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | -50.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | -48.13 Mn |
| 10 | Teleflex | 5.80 Bn | 5.49 Bn | 307.43 Mn | -44.99 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -44.99 Mn |
| Mar 31, 2026 | -44.99 Mn |
| Dec 31, 2025 | -61.61 Mn |
| Dec 31, 2025 | -61.61 Mn |
| Sep 28, 2025 | 756.34 Mn |
| Sep 28, 2025 | 756.34 Mn |
| Jun 29, 2025 | -23.67 Mn |
| Jun 29, 2025 | -23.67 Mn |
| Mar 30, 2025 | -59.52 Mn |
| Mar 30, 2025 | -59.52 Mn |
| Dec 31, 2024 | -119.12 Mn |
| Dec 31, 2024 | -119.12 Mn |
| Sep 29, 2024 | -174.82 Mn |
| Sep 29, 2024 | -174.82 Mn |
| Jun 30, 2024 | -56.54 Mn |
| Jun 30, 2024 | -56.54 Mn |
| Mar 31, 2024 | -71.45 Mn |
| Mar 31, 2024 | -71.45 Mn |
| Dec 31, 2023 | -237.50 Mn |
| Dec 31, 2023 | -237.50 Mn |